annual D&A:
$6.07B-$2.21B(-26.72%)Summary
- As of today (August 23, 2025), NVS annual depreciation & amortization is $6.07 billion, with the most recent change of -$2.21 billion (-26.72%) on December 31, 2024.
- During the last 3 years, NVS annual D&A has risen by +$636.57 million (+11.73%).
- NVS annual D&A is now -26.72% below its all-time high of $8.28 billion, reached on December 31, 2023.
Performance
NVS Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.18B+$25.63M(+2.22%)Summary
- As of today (August 23, 2025), NVS quarterly depreciation & amortization is $1.18 billion, with the most recent change of +$25.63 million (+2.22%) on June 30, 2025.
- Over the past year, NVS quarterly D&A has increased by +$17.63 million (+1.52%).
- NVS quarterly D&A is now -62.08% below its all-time high of $3.11 billion, reached on September 30, 2023.
Performance
NVS quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.93B+$17.63M(+0.30%)Summary
- As of today (August 23, 2025), NVS TTM depreciation & amortization is $5.93 billion, with the most recent change of +$17.63 million (+0.30%) on June 30, 2025.
- Over the past year, NVS TTM D&A has dropped by -$1.25 billion (-17.40%).
- NVS TTM D&A is now -30.39% below its all-time high of $8.51 billion, reached on September 30, 2023.
Performance
NVS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVS Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.7% | +1.5% | -17.4% |
| 3 y3 years | +11.7% | -34.5% | +7.8% |
| 5 y5 years | +4.1% | -30.7% | -8.1% |
NVS Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.7% | +11.7% | -62.1% | +2.2% | -30.4% | +7.8% |
| 5 y | 5-year | -26.7% | +18.7% | -62.1% | +348.5% | -30.4% | +22.0% |
| alltime | all time | -26.7% | +581.0% | -62.1% | +893.1% | -30.4% | +1849.5% |
NVS Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.18B(+2.2%) | $5.93B(+0.3%) |
| Mar 2025 | - | $1.15B(-29.1%) | $5.91B(-2.6%) |
| Dec 2024 | $6.07B(-26.7%) | $1.63B(-17.2%) | $6.07B(+0.7%) |
| Sep 2024 | - | $1.97B(+69.1%) | $6.03B(-16.0%) |
| Jun 2024 | - | $1.16B(-11.6%) | $7.17B(-7.1%) |
| Mar 2024 | - | $1.31B(-17.3%) | $7.72B(-6.8%) |
| Dec 2023 | $8.28B(+23.4%) | $1.59B(-49.0%) | $8.28B(-2.7%) |
| Sep 2023 | - | $3.11B(+82.2%) | $8.51B(+20.3%) |
| Jun 2023 | - | $1.71B(-8.9%) | $7.08B(-1.3%) |
| Mar 2023 | - | $1.87B(+2.9%) | $7.17B(+7.0%) |
| Dec 2022 | $6.71B(+23.5%) | $1.82B(+8.7%) | $6.71B(+17.3%) |
| Sep 2022 | - | $1.68B(-7.0%) | $5.72B(+4.1%) |
| Jun 2022 | - | $1.80B(+28.3%) | $5.50B(+7.0%) |
| Mar 2022 | - | $1.41B(+68.3%) | $5.14B(-5.4%) |
| Dec 2021 | $5.43B(+6.2%) | $835.00M(-42.5%) | $5.43B(+11.8%) |
| Sep 2021 | - | $1.45B(+0.6%) | $4.86B(-5.5%) |
| Jun 2021 | - | $1.44B(-14.9%) | $5.14B(-4.8%) |
| Mar 2021 | - | $1.70B(+545.2%) | $5.40B(+5.6%) |
| Dec 2020 | $5.11B(-12.3%) | $263.00M(-84.8%) | $5.11B(-24.7%) |
| Sep 2020 | - | $1.73B(+1.8%) | $6.78B(+5.1%) |
| Jun 2020 | - | $1.70B(+20.8%) | $6.45B(+11.3%) |
| Mar 2020 | - | $1.41B(-27.2%) | $5.79B(-0.5%) |
| Dec 2019 | $5.83B(+11.8%) | $1.94B(+38.2%) | $5.83B(+5.4%) |
| Sep 2019 | - | $1.40B(+34.0%) | $5.53B(+0.7%) |
| Jun 2019 | - | $1.05B(-27.4%) | $5.49B(-2.8%) |
| Mar 2019 | - | $1.44B(-11.9%) | $5.65B(+8.4%) |
| Dec 2018 | $5.21B(+0.0%) | $1.64B(+19.9%) | $5.21B(+24.8%) |
| Sep 2018 | - | $1.36B(+13.3%) | $4.18B(-2.6%) |
| Jun 2018 | - | $1.21B(+19.9%) | $4.29B(-3.4%) |
| Mar 2018 | - | $1.00B(+66.9%) | $4.44B(-14.8%) |
| Dec 2017 | $5.21B(-2.6%) | $602.00M(-59.3%) | $5.21B(-7.2%) |
| Sep 2017 | - | $1.48B(+9.2%) | $5.62B(-0.5%) |
| Jun 2017 | - | $1.35B(-23.8%) | $5.64B(-1.9%) |
| Mar 2017 | - | $1.78B(+76.4%) | $5.76B(+7.6%) |
| Dec 2016 | $5.35B(+2.4%) | $1.01B(-33.2%) | $5.35B(-1.3%) |
| Sep 2016 | - | $1.51B(+2.9%) | $5.42B(+2.9%) |
| Jun 2016 | - | $1.47B(+7.1%) | $5.27B(-0.8%) |
| Mar 2016 | - | $1.37B(+26.9%) | $5.31B(+1.7%) |
| Dec 2015 | $5.22B(+19.8%) | $1.08B(-20.4%) | $5.22B(+3.5%) |
| Sep 2015 | - | $1.35B(-10.2%) | $5.05B(+4.7%) |
| Jun 2015 | - | $1.51B(+17.7%) | $4.82B(+9.8%) |
| Mar 2015 | - | $1.28B(+42.3%) | $4.39B(+0.7%) |
| Dec 2014 | $4.36B(-6.5%) | $901.00M(-20.1%) | $4.36B(-10.5%) |
| Sep 2014 | - | $1.13B(+4.4%) | $4.87B(+0.6%) |
| Jun 2014 | - | $1.08B(-13.7%) | $4.84B(+2.7%) |
| Mar 2014 | - | $1.25B(-11.4%) | $4.71B(+1.1%) |
| Dec 2013 | $4.66B(+1.4%) | $1.41B(+28.7%) | $4.66B(+7.7%) |
| Sep 2013 | - | $1.10B(+15.0%) | $4.33B(-3.9%) |
| Jun 2013 | - | $953.98M(-20.5%) | $4.50B(-4.5%) |
| Mar 2013 | - | $1.20B(+11.4%) | $4.71B(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $4.60B(-2.3%) | $1.08B(-15.3%) | $4.60B(+9.7%) |
| Sep 2012 | - | $1.27B(+9.0%) | $4.19B(-2.0%) |
| Jun 2012 | - | $1.17B(+7.5%) | $4.28B(-5.2%) |
| Mar 2012 | - | $1.08B(+61.8%) | $4.51B(-4.1%) |
| Dec 2011 | $4.71B(+89.9%) | $670.06M(-50.7%) | $4.71B(+21.1%) |
| Sep 2011 | - | $1.36B(-3.0%) | $3.89B(+3.3%) |
| Jun 2011 | - | $1.40B(+9.5%) | $3.76B(+25.6%) |
| Mar 2011 | - | $1.28B(-959.6%) | $3.00B(+20.9%) |
| Dec 2010 | $2.48B(+9.8%) | -$148.74M(-112.1%) | $2.48B(-23.7%) |
| Sep 2010 | - | $1.23B(+94.6%) | $3.25B(+25.6%) |
| Jun 2010 | - | $633.20M(-16.8%) | $2.59B(+4.1%) |
| Mar 2010 | - | $760.93M(+22.3%) | $2.49B(+10.1%) |
| Dec 2009 | $2.26B(-1.9%) | $622.41M(+9.0%) | $2.26B(+3.2%) |
| Sep 2009 | - | $571.17M(+7.4%) | $2.19B(+0.2%) |
| Jun 2009 | - | $531.60M(-0.1%) | $2.18B(-3.1%) |
| Mar 2009 | - | $532.03M(-3.7%) | $2.25B(-2.1%) |
| Dec 2008 | $2.30B(-19.5%) | $552.21M(-2.5%) | $2.30B(+31.6%) |
| Sep 2008 | - | $566.30M(-5.7%) | $1.75B(-18.3%) |
| Jun 2008 | - | $600.75M(+3.4%) | $2.14B(+1.8%) |
| Mar 2008 | - | $580.74M(-39.4%) | $2.10B(+1.4%) |
| Dec 2007 | $2.86B(+48.6%) | - | - |
| Sep 2007 | - | $958.37M(+70.5%) | $2.07B(+24.0%) |
| Jun 2007 | - | $562.07M(+1.7%) | $1.67B(+10.1%) |
| Mar 2007 | - | $552.56M(-0.9%) | $1.52B(-21.6%) |
| Dec 2006 | $1.92B(+14.5%) | - | - |
| Sep 2006 | - | $557.53M(+36.7%) | $1.94B(+3.2%) |
| Jun 2006 | - | $408.00M(-4.7%) | $1.88B(+6.5%) |
| Mar 2006 | - | $428.00M(-21.3%) | $1.76B(+8.8%) |
| Dec 2005 | $1.68B(+26.1%) | $544.00M(+9.2%) | $1.62B(+14.1%) |
| Sep 2005 | - | $498.00M(+69.4%) | $1.42B(+13.4%) |
| Jun 2005 | - | $294.00M(+3.2%) | $1.25B(-1.7%) |
| Mar 2005 | - | $285.00M(-17.2%) | $1.27B(-1.8%) |
| Dec 2004 | $1.33B(+4.5%) | $344.00M(+4.2%) | $1.30B(+1.2%) |
| Sep 2004 | - | $330.00M(+4.4%) | $1.28B(-2.4%) |
| Jun 2004 | - | $316.00M(+2.3%) | $1.31B(+2.1%) |
| Mar 2004 | - | $309.00M(-6.1%) | $1.29B(+0.4%) |
| Dec 2003 | $1.27B(-1.5%) | $329.00M(-8.9%) | $1.28B(+34.5%) |
| Sep 2003 | - | $361.00M(+24.9%) | $954.00M(+60.9%) |
| Jun 2003 | - | $289.00M(-4.9%) | $593.00M(+95.1%) |
| Mar 2003 | - | $304.00M | $304.00M |
| Dec 2002 | $1.29B(+24.9%) | - | - |
| Dec 2001 | $1.04B(+16.3%) | - | - |
| Dec 2000 | $890.68M(-11.2%) | - | - |
| Dec 1999 | $1.00B(+4.7%) | - | - |
| Dec 1998 | $957.81M(+7.5%) | - | - |
| Dec 1997 | $890.68M(-43.1%) | - | - |
| Dec 1996 | $1.57B(-1.5%) | - | - |
| Dec 1995 | $1.59B(+16.2%) | - | - |
| Dec 1994 | $1.37B(+5.9%) | - | - |
| Dec 1993 | $1.29B | - | - |
FAQ
- What is Novartis AG annual depreciation & amortization?
- What is the all time high annual D&A for Novartis AG?
- What is Novartis AG annual D&A year-on-year change?
- What is Novartis AG quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Novartis AG?
- What is Novartis AG quarterly D&A year-on-year change?
- What is Novartis AG TTM depreciation & amortization?
- What is the all time high TTM D&A for Novartis AG?
- What is Novartis AG TTM D&A year-on-year change?
What is Novartis AG annual depreciation & amortization?
The current annual D&A of NVS is $6.07B
What is the all time high annual D&A for Novartis AG?
Novartis AG all-time high annual depreciation & amortization is $8.28B
What is Novartis AG annual D&A year-on-year change?
Over the past year, NVS annual depreciation & amortization has changed by -$2.21B (-26.72%)
What is Novartis AG quarterly depreciation & amortization?
The current quarterly D&A of NVS is $1.18B
What is the all time high quarterly D&A for Novartis AG?
Novartis AG all-time high quarterly depreciation & amortization is $3.11B
What is Novartis AG quarterly D&A year-on-year change?
Over the past year, NVS quarterly depreciation & amortization has changed by +$17.63M (+1.52%)
What is Novartis AG TTM depreciation & amortization?
The current TTM D&A of NVS is $5.93B
What is the all time high TTM D&A for Novartis AG?
Novartis AG all-time high TTM depreciation & amortization is $8.51B
What is Novartis AG TTM D&A year-on-year change?
Over the past year, NVS TTM depreciation & amortization has changed by -$1.25B (-17.40%)